Submit Deal

AZERIA THERAPEUTICS

Summary

Azeria Therapeutics operates as a biotechnology company. The Company focuses on drugs discovery and treatments for hormone resistant breast and postate cancer patients. Azeria Therapeutics serves patients in the United Kingdom.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 32 M

Avg. Deal Size£ 32 M

Market Context

Senior Management

Stephen Myatt
CEO

Sort

fti consulting

HQ - Washington DC

pr advisors (1)

1 Shared Deal

1 Opposite

£ 32 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy